Keyphrases
Oral Anticoagulation
100%
Atrial Fibrillation
100%
Warfarin
100%
Chronic Dialysis
100%
Randomized Controlled Trial
100%
Dialysis
100%
Vitamin K Antagonists
80%
Randomized Clinical Trial
40%
Antagonist Treatment
40%
Principal Coordinate Analysis (PCoA)
20%
Stroke Risk
20%
Primary Safety
20%
Clinical Trial Design
20%
Safety Endpoints
20%
Investigator-initiated Trials
20%
Anticoagulant Therapy
20%
Peer-reviewed Journals
20%
Dialysis Facility
20%
Major Bleeding
20%
Anticoagulation
20%
Research Meeting
20%
Patient's Will
20%
Research Ethics Committees
20%
International Normalized Ratio
20%
Anticoagulants
20%
Regional Research
20%
Overall Benefit
20%
Declaration of Helsinki
20%
Stroke Prevention
20%
Efficacy Endpoint
20%
Good Clinical Practice
20%
Transient Ischemic Attack
20%
Stroke Ischemic
20%
Risk Reduction
20%
Medicine and Dentistry
Randomized Controlled Trial
100%
Atrial Fibrillation
100%
Vitamin K Antagonist
100%
Anticoagulation
100%
Warfarin
100%
Apoplexy
75%
Randomized Clinical Trial
50%
Transient Ischemic Attack
25%
Anticoagulant Therapy
25%
Hemodialysis
25%
Risk Reduction
25%
Medicine
25%
Antithrombotic
25%
Major Bleeding
25%
Pharmacology, Toxicology and Pharmaceutical Science
Antivitamin K
100%
Randomized Controlled Trial
100%
Warfarin
100%
Atrial Fibrillation
100%
Anticoagulant Agent
50%
Randomized Clinical Trial
50%
Bleeding
25%
Transient Ischemic Attack
25%
Hemodialysis
25%